ADAs to Alemtuzumab
Condition(s):Multiple SclerosisLast Updated:March 15, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Multiple SclerosisLast Updated:March 15, 2024Active, not recruiting
Condition(s):SeminomaLast Updated:March 13, 2024Recruiting
Condition(s):Testicular NeoplasmsLast Updated:March 13, 2024Completed
Condition(s):Periodontal Diseases; Wound Heal; Periodontal Inflammation; Periodontal Pocket; Periodontal Attachment LossLast Updated:March 13, 2024Not yet recruiting
Condition(s):Infective EndocarditisLast Updated:March 13, 2024Recruiting
Condition(s):Dental Implant; Healing Wound; Biomarkers; SalivaLast Updated:March 8, 2024Not yet recruiting
Condition(s):Laparoscopic Skills AcquisitionLast Updated:December 28, 2023Completed
Condition(s):Parkinson’s Disease and Parkinsonism; Progressive Supranuclear Palsy; Tremor; Dystonia; Multiple System Atrophy; Corticobasal Degeneration; Vascular ParkinsonismLast Updated:February 20, 2024Not yet recruiting
Condition(s):Out-Of-Hospital Cardiac Arrest; Cardiac Arrest; Cardiac Arrhythmia; Ventricular Fibrillation; Ventricular Arrythmia; Pulseless Electrical ActivityLast Updated:February 14, 2024Not yet recruiting
Condition(s):Myocardial Infarction; ST Elevation Myocardial Infarction; Non-ST Elevation Myocardial InfarctionLast Updated:September 15, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.